Clinical Supply, FDA Approval and Pharmaceutical Companies

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Clinical Supply

FDA Approval

Pharmaceutical Companies

PharmaDrug Enters Definitive Agreement for Acquisition of Sairiyo Therapeutics Inc. Who Recently Received Orphan Drug Designation from FDA for Esophageal Cancer

The Pharma Data

JANUARY 24, 2021

In clinical research, Cepharanthine exhibits multiple pharmacological properties including anti-oxidative, anti-inflammatory, immuno-regulatory, anti-cancer, anti-viral and anti-parasitic properties. Sairiyo is currently focused on advancing the clinical development of Cepharanthine to treat rare cancer diseases. About PharmaDrug Inc.

FDA

FDA Drugs Clinical Development Pharmaceutical Companies

[Podcast] Trial Trailblazers: Behind clinical breakthroughs

BioPharma Drive: Drug Pricing

JUNE 9, 2025

From pioneering treatments for rare pediatric diseases to exploring natural killer cells for Alzheimers and developing FDA-approved digital therapeutics for fibromyalgia, each episode reveals the scientific ingenuity and personal determination behind medical advances. 3 Digital Behavioral Therapy for Fibromyalgia Ep.

Trials

Trials Clinical Supply Clinical Trials Therapies

Drug Discovery Digest

PharmaDrug Enters Definitive Agreement for Acquisition of Sairiyo Therapeutics Inc. Who Recently Received Orphan Drug Designation from FDA for Esophageal Cancer

[Podcast] Trial Trailblazers: Behind clinical breakthroughs

Stay Connected